Cargando…
Management of ocular inflammation and pain following cataract surgery: focus on bromfenac ophthalmic solution
Recently, several new ophthalmic NSAID products have been introduced for commercial use in the United States. The purpose of this review is to briefly overview the ophthalmic NSAIDs currently in use and to discuss the management of postoperative ocular inflammation and pain following cataract surger...
Autores principales: | Cho, Hyung, Wolf, Kenneth J, Wolf, Eric J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2709021/ https://www.ncbi.nlm.nih.gov/pubmed/19668566 |
Ejemplares similares
-
Bromfenac ophthalmic solution for the treatment of postoperative ocular pain and inflammation: safety, efficacy, and patient adherence
por: Rajpal, Rajesh K, et al.
Publicado: (2014) -
In Vivo Pharmacokinetics of Bromfenac Ophthalmic Solution 0.075%, Bromfenac Ophthalmic Solution 0.07%, and Nepafenac/Amfenac Ophthalmic Suspension 0.3% in Rabbits
por: Sheppard, John D., et al.
Publicado: (2018) -
Use of topical bromfenac for treating ocular pain and inflammation beyond cataract surgery: a review of published studies
por: Schechter, Barry A
Publicado: (2019) -
Update on twice-daily bromfenac sodium sesquihydrate to treat postoperative ocular inflammation following cataract extraction
por: Carreño, Ester, et al.
Publicado: (2012) -
The ocular distribution of (14)C-labeled bromfenac ophthalmic solution 0.07% in a rabbit model
por: Baklayan, George A, et al.
Publicado: (2014)